2019年度　Journal Club

Oncology

No.

日付

Title: Journal PMID.

担当者

まとめ

 3 5th/June Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201). Lung Cancer 2019 31097051 福田 濱元
 2 3rd/April      

井部

濱田
 1 10th/Apr

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial 

Lancet 2019

30922878 濱元 石井

COPD&Asthma

No.

日付

Title: Journal PMID.

担当者

まとめ

 1            

Infection

No.

日付

Title: Journal PMID

担当者

まとめ

1 3rd/April

Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.

Lancet2019 30799062 大越 石井

Allergy

No.

日付

Title: Journal PMID

担当者

まとめ

1            

Other

No.

日付

Title: Journal PMID

担当者

まとめ

1  29th/May  Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis  NEJM2019  30304656  中村 濵元